WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry. The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable. “The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release. |
Texas university leaders say hundreds of positions, programs cut to comply with DEI banAgreement boosts joint work on parksGiancarlo Stanton's HR, Carlos Rodón's 6Here are the locations that Red Lobster is closing in the USYankees injuries: DJ LeMahieu nears rehab assignment, Gerrit Cole throws another bullpenAstros starter Ronel Blanco ejected in the fourth inning after a foreign substance checkPirates designate LHP Josh Fleming for assignment one night after a poor relief performanceDelhi stays alive for IPL playoffs with 19China's tech giant Huawei hosts cloud database summit in ThailandAstros get 2